At diagnosis and prior to NAC, there were no significant differences in the levels of circulating (%, AbNs) and tumour-infiltrating T cells (FOXP3+, CTLA-4+) and the subsequent different NAC response groups (good pathological response versus poor pathological response and pCR versus non-pCR) (see Additional File 4). This evidence concerns the gene FOXP3 and neoplasm.